Our findings underscore the pivotal role of fibroblasts in aortic progeria-associated vascular remodeling in HGPS mice and suggest that Lgals3bp may represent a potential therapeutic target for aortic pathology in HGPS. This evidence concerns the gene LGALS3BP and progeroid syndrome.